Amber Welle

PHD Doctor of Philosophy,  Mayo Clinic - Rochester 

Location: India

Consulting Services

Journal Manuscript Legal Support

Areas Of Interest

Permanent Vegetative State Sol-Gel Phase Transitions Boiling Point Temperature Interpretations, Psychoanalytical Common Horse Chestnuts Osmotic Stress Response Mutant Mouse Strains Lemuridae Guanylyl Imidodiphosphate Pregnanolone, (3beta, 5alpha, 17alpha)-isomer Coronary Angiography TUT7 Transfer, Nerve Grey Mangrove Colitis, Pseudomembranous Leukemias, T Lymphocytic Cells, Reed-Sternberg Leukoencephalopathy Syndrome, Sturge-Kalischer-Weber American Speech-Language-Hearing Association Parasympatholytic Effects Colicin E2 P2X7 Purinoceptor Agonists Deficiency Disease, Pyruvate Carboxylase IL4 Receptors Hairless Mouse Ocular Parallax Anthranol Methyltransferase, Norepinephrine Cadavers Proton-Translocating ATPase Tennis Acid, 99mTc-Dimercaptosuccinic Angiographies, Magnetic Resonance Phospholipid-Dependent Kinase, Calcium-Activated Pathway, Signal Opioid Receptor, delta

Professional Narrative

Dr. Amber Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Senior Director, Harvard Med 1990
Executive Director, Harvard Med 1996

Education

Doctor of medicine, Yale School of Medicine 2012
Doctor of osteopathic medicine, Perelman School of Medicine 1993

Referees

Publications

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02